About
At Charles River our focus is always on anticipating tomorrow’s drug development needs today and this is why we have invested in the tools, talent and capacity to further the new frontier of cell and gene therapy development. We can support your cell and gene therapy programs every step of the way, from early discovery, manufacturing of viral vectors, plasmid and autologous/allogenic cells toxicity/toxicology studies, to analytical release testing of your cell line characterisation, biosafety and potency testing. Our global footprint, team of experienced professionals and unsurpassed portfolio of integrated services are dedicated to supporting you to help get your product to patients faster.
Evonne Fearnot
Senior Marketing ManagerMarketing 003539620800
evonne.fearnot@crl.com
Address
Carrentrila
Ballina
F26 D786
Mayo
Ireland
evonne.fearnot@crl.com
Areas of Expertise
- Analytics
- Cell therapy (Allogeneic)
- Cell Therapy (Autologous)
- Chemical synthesis
- Delivery
- Discovery
- Gene Therapy (non-viral)
- Gene therapy (viral)
- Manufacturing sciences
- Microscopy/Imaging
- Omics
- Process Development
- Regulatory
- Vaccines